Immunization
GSK begins shipments of Fluarix® and FluLaval® to U.S. customers for 2008-2009 influenza season
Published in Vaccine Weekly, August 27th, 2008
GlaxoSmithKline [NYSE: GSK] announced that it will begin shipment of FLULAVAL® [Influenza Virus Vaccine] and FLUARIX® [Influenza Virus Vaccine] to U.S. customers for the 2008-2009 influenza season. The U.S. Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research (CBER) released the first lots of FLULAVAL and FLUARIX, allowing distribution to begin. GSK plans to supply the U.S. market with approximately 35 million doses of the two products combined – an increase from last year, when GSK contributed approximately 33 million doses.
GSK anticipates delivery of at least half of its influenza vaccines by the end of August and the vast majority...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2008-08-27)
More Articles from Vaccine Weekly
- Elsevier
Towards understanding bluetongue outbreaks - African Trypanosomiasis
Report summarizes african trypanosomiasis study findings from Radboud University - Chickenpox
Study findings on chickenpox are outlined in reports from Deakin University - Encephalitis
Study results from T. Jelinek and colleagues update understanding of encephalitis - Flu Vaccines
Research conducted at University of Zurich, World Health Organization has updated our knowledge about flu vaccines - Gene Therapy
Researchers from Michigan State University report recent findings in gene therapy - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
